Pros | - | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | - | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 4 Years 3 Months | 13 Years 3 Months | ||
Fund AUM | ₹224 Cr | ₹8265 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.47% | 0.92% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 41 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 4 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.28% | 97.37% | ||
Debt % | - | - | ||
P/E | 42 | 34.75 | ||
P/B | 5.73 | 5.37 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -7.02% | -4.25% | ||
3-Month Return | -9.05% | -3.24% | ||
6-Month Return | -6.89% | -1.12% | ||
1-Year Return | -7.99% | 0.6% | ||
3-Year Return | 19.69% | 23.12% | ||
5-Year Return | - | 15% |
Sharpe | 0.77 | 0.97 | ||
Alpha | -1.29 | 0.33 | ||
Beta | 0.92 | 0.9 | ||
Standard Deviation | 16.22 | 15.32 | ||
Information Ratio | -0.57 | -0.32 |
Description | ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhimant Shah, Rohan Korde | Sailesh Raj Bhan, Lokesh Maru, Kinjal Desai, Divya Sharma |